Cited by 228Phytochemicals and Medicinal PlantsParkinson's Disease Mechanisms and TreatmentsMedicinal Plants and Neuroprotection

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats

Ahmad, Muzamil, Saleem, Sofiyan, Ahmad, Abdullah Shafique, Ansari, Mubeen Ahmad, Yousuf, Seema, Hoda, Md Nasrul, Islam, Fakhrul·2005·Human & Experimental Toxicology

DOI 10.1191/0960327105ht509oa

Open this paper in CoChat — free account

Abstract

6-Hydroxydopamine (6-OHDA) is one of the most widely used rat models for Parkinson's disease. There is ample evidence in the literature that 6-OHDA elicits its toxic manifestations through oxidant stress. In the present study, we evaluated the anti-parkinsonian effects of Withania somnifera extract, which has been reported to have potent anti-oxidant, anti-peroxidative and free radical quenching properties in various diseased conditions. Rats were pretreated with 100, 200 and 300 mg/kg b.w. of the W. somnifera extract orally for 3 weeks. On day 21, 2 microL of 6-OHDA (10 microg in 0.1% in ascorbic acid-saline) was infused into the right striatum while sham operated group received 2 microL of the vehicle. Three weeks after 6-OHDA injections, rats were tested for neurobehavioral activity and were killed 5 weeks after lesioning for the estimation of lipidperoxidation, reduced glutathione content, activities of glutathione-S-transferase, glutathione reductase, glutathione peroxidase, superoxide dismutase and catalase, catecholamine content, dopaminergic D2 receptor binding and tyrosine hydroxylase expression. W. somnifera extract was found to reverse all the parameters significantly in a dose-dependent manner. Thus, the study demonstrates that the extract of W. somnifera may be helpful in protecting the neuronal injury in Parkinson's disease.

Integrity signals

Registry

Crossref · 10.1191/0960327105ht509oa

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Glutathione S-Transferases
Habig, W. H., Pabst, M. J., & Jakoby, W. B. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42083-8 · Cited by 18,509
Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels
Beauchamp, C., & Fridovich, I. (1971) · Analytical Biochemistry · doi:10.1016/0003-2697(71)90370-8 · Cited by 12,892
Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Indian Journal of Experimental Biology
(2022) · Indian Journal of Experimental Biology · doi:10.56042/ijeb · Cited by 3,397
Bromobenzene-Induced Liver Necrosis. Protective Role of Glutathione and Evidence for 3,4-Bromobenzene Oxide as the Hepatotoxic Metabolite
Jollow, D. J., Mitchell, J. R., ZAMPAGLIONE, N. G., & Gillette, J. R. (2008) · Pharmacology · doi:10.1159/000136485 · Cited by 3,291
Biology of disease: free radicals and tissue injury.
Freeman, B. Α., & Jd, C. (1982) · PubMed · Cited by 3,038
Handbook of methods for oxygen radical research
Greenwald, R. A. (1987) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(87)80012-6 · Cited by 2,388
Purification and characterization of the flavoenzyme glutathione reductase from rat liver.
Carlberg, I., & Mannervik, B. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41206-4 · Cited by 2,024

Show all 51 references

Research works printed but not linked: 4

Mishra LC, 2000, Alternive Medicine Reviews, 5, 334
Panda S, 1997, Indian Journal of Physiology Pharmacology, 41, 424
Mohandas J, 1984, Cancer Research, 44, 5086
Cohen G, 1984, Neurotoxicology, 5, 77

Sorted by citations

Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
Rahal, A., Kumar, A., Singh, V., Yadav, B., Tiwari, R., Chakraborty, S., & Dhama, K. (2014) · BioMed Research International · doi:10.1155/2014/761264 · Cited by 1,806
Steroidal Lactones from Withania somnifera, an Ancient Plant for Novel Medicine
Mirjalili, M. H., Moyano, E., Bonfill, M., Cusido, R. M., & Palazón, J. (2009) · Molecules · doi:10.3390/molecules14072373 · Cited by 657
Withania somnifera: an Indian ginseng
Kulkarni, S. K., & Dhir, A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.011 · Cited by 416
Pharmacologic overview of Withania somnifera, the Indian Ginseng
Dar, N. J., Hamid, A., & Ahmad, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2012-1 · Cited by 391
Self-citation
Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review
Mikulska, P., Malinowska, M., Ignacyk, M., Szustowski, P., Nowak, J., Pesta, K., Szeląg, M., Szklanny, D., Judasz, E., Kaczmarek, G., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041057 · Cited by 387
Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects
Paul, S., Chakraborty, S., Anand, U., Dey, S., Nandy, S., Ghorai, M., Saha, S. C., Patil, M. T., Kandimalla, R., Proćków, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112175 · Cited by 306
Withaferin A Causes FOXO3a- and Bim-Dependent Apoptosis and Inhibits Growth of Human Breast Cancer Cells In vivo
Stan, S. D., Hahm, E., Warin, R., & Singh, S. V. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1510 · Cited by 265
Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases
Sairazi, N. S. M., & Sirajudeen, K. N. S. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/6565396 · Cited by 260
Withaferin A-Induced Apoptosis in Human Breast Cancer Cells Is Mediated by Reactive Oxygen Species
Hahm, E., de Moura, M. B., Kelley, E. E., Houten, B. V., Shiva, S., & Singh, S. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023354 · Cited by 247
The Tumor Proteasome Is a Primary Target for the Natural Anticancer Compound Withaferin A Isolated from “Indian Winter Cherry”
Yang, H., Shi, G., & Dou, Q. P. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030015 · Cited by 227
Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective.
Saleem, S., Muhammad, G., Hussain, M. A., Altaf, M., & Bukhari, S. N. A. (2020) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2020.44254.10378 · Cited by 199
Self-citation
Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda
Mukherjee, P. K., Banerjee, S., Biswas, S., Das, B., Kar, A., & Katiyar, C. K. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113157 · Cited by 180
Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Li, S., & Pu, X. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1291 · Cited by 149
Nootropic herbs (Medhya Rasayana) in Ayurveda: An update
Kulkarni, R., J, G. K., & Kumar, A. (2012) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · doi:10.4103/0973-7847.99949 · Cited by 156
Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers
Raut, A., Rege, N., Shirolkar, S., Pandey, S., Tadvi, F., Solanki, P. V., Vaidya, R., Vaidya, A., & Kene, K. (2012) · Journal of Ayurveda and Integrative Medicine · doi:10.4103/0975-9476.100168 · Cited by 153
Ayurvedic Medicine Constituent Withaferin A Causes G2 and M Phase Cell Cycle Arrest in Human Breast Cancer Cells
Stan, S. D., Zeng, Y., & Singh, S. V. (2008) · Nutrition and Cancer · doi:10.1080/01635580802381477 · Cited by 150
Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects
Mandlik, D. S., & Namdeo, A. G. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2020.1741484 · Cited by 149
Anti-apoptotic and Anti-inflammatory effect of Piperine on 6-OHDA induced Parkinson's Rat model
Shrivastava, P., Vaibhav, K., Tabassum, R., Khan, A., Ishrat, T., Khan, M. M., Ahmad, A., Islam, F., Safhi, M. M., & Islam, F. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.03.018 · Cited by 146
Self-citation
Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells
Lee, J., Hahm, E., & Singh, S. V. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq175 · Cited by 147
Natural Withanolides in the Treatment of Chronic Diseases
White, P. T., Subramanian, C., Motiwala, H. F., & Cohen, M. S. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-41334-1_14 · Cited by 139
Effect of Withania somnifera (Ashwagandha) on the Development of Chemotherapy-Induced Fatigue and Quality of Life in Breast Cancer Patients
Biswal, B. M., Sulaiman, S. A., Ismail, H. C., Zakaria, H., & Musa, K. I. (2013) · Integrative Cancer Therapies · doi:10.1177/1534735412464551 · Cited by 131
Ashwagandha (Withania somnifera) Reverses β-Amyloid1-42 Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)
Kurapati, K. R. V., Atluri, V. S. R., Samikkannu, T., & Nair, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077624 · Cited by 130
Effects of Ashwagandha (Roots of Withania somnifera) on Neurodegenerative Diseases
Kuboyama, T., Tohda, C., & Komatsu, K. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00022 · Cited by 127
Neurodegenerative diseases and Withania somnifera (L.): An update
Dar, N. J., & Ahmad, M. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112769 · Cited by 123
The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: An analysis of behavioral and biochemical varibles
Sankar, S. R., Manivasagam, T., Krishnamurti, A., & Ramanathan, M. (2007) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-007-0015-0 · Cited by 119
Withaferin A inhibits tumor necrosis factor-α-induced expression of cell adhesion molecules by inactivation of Akt and NF-κB in human pulmonary epithelial cells
Oh, J. H., & Kwon, T. K. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.02.002 · Cited by 118
Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism
Kosaraju, J., Chinni, S., Roy, P., Kannan, E., Antony, A., & Kumar, M. N. S. (2014) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.129312 · Cited by 113
Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies
Ahmad, M., Yousuf, S., Khan, M. B., Hoda, M. N., Ahmad, A. S., Ansari, M. A., Ishrat, T., Agrawal, A. K., & Islam, F. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.01.005 · Cited by 104
Self-citation
Anti-Parkinsonian drug discovery from herbal medicines: What have we got from neurotoxic models?
Song, J., Sze, S. C. W., Ng, T., Lee, C., Leung, G., Shaw, P., Tong, Y., & Zhang, Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.030 · Cited by 102
Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression
Hahm, E., & Singh, S. V. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.026 · Cited by 100
Neuroprotective Effects of Withania somnifera Dunal.: A Possible Mechanism
Bhatnagar, M., Sharma, D., & Salvi, M. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9987-7 · Cited by 95
Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: Behavioral, neurochemical and immunohistochemical studies
Khuwaja, G., Khan, M. M., Ishrat, T., Ahmad, A., Raza, S. S., Ashafaq, M., Javed, H., Khan, M. B., Khan, A., Vaibhav, K., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.023 · Cited by 94
Self-citation
Silymarin protects neurons from oxidative stress associated damages in focal cerebral ischemia: A behavioral, biochemical and immunohistological study in Wistar rats
Raza, S. S., Khan, M. M., Ashafaq, M., Ahmad, A., Khuwaja, G., Khan, A., Siddiqui, M. S., Safhi, M. M., & Islam, F. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.07.035 · Cited by 93
Self-citation
Metabolic Alterations in Mammary Cancer Prevention by Withaferin A in a Clinically Relevant Mouse Model
Hahm, E., Lee, J., Kim, S., Sehrawat, A., Arlotti, J. A., Shiva, S. S., Bhargava, R., & Singh, S. V. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt153 · Cited by 93
Water Extract of Ashwagandha Leaves Has Anticancer Activity: Identification of an Active Component and Its Mechanism of Action
Wadhwa, R., Singh, R., Gao, R., Shah, N., Widodo, N., Nakamoto, T., Ishida, Y., Terao, K., & Kaul, S. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077189 · Cited by 90
Neuroprotection and free radical scavenging effects of Osmanthus fragrans
Lee, H.-H., Lin, C.-T., & Yang, L.-L. (2007) · Journal of Biomedical Science · doi:10.1007/s11373-007-9179-x · Cited by 87
Important medicinal herbs in Parkinson’s disease pharmacotherapy
Srivastav, S., Fatima, M., & Mondal, A. C. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.137 · Cited by 87
Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
Limanaqi, F., Biagioni, F., Busceti, C. L., Ryskalin, L., Polzella, M., Frati, A., & Fornai, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133274 · Cited by 87
In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β‐amyloid(1–42)‐induced cytotoxicity in differentiated PC12 cells
Kumar, S., Seal, C. J., Howes, M. R., Kite, G. C., & Okello, E. J. (2010) · Phytotherapy Research · doi:10.1002/ptr.3261 · Cited by 84
Withaferin a suppresses estrogen receptor‐α expression in human breast cancer cells
Hahm, E., Lee, J., Huang, Y., & Singh, S. V. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20760 · Cited by 87
Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim
Velmurugan, K., Alam, J., McCord, J. M., & Pugazhenthi, S. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.050 · Cited by 80
Effect of dietary sesame oil as antioxidant on brain hippocampus of rat in focal cerebral ischemia
Ahmad, S., Yousuf, S., Ishrat, T., Khan, M. B., Bhatia, K., Fazili, I. S., Khan, J., Ansari, N. H., & Islam, F. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.06.017 · Cited by 78
Self-citation
Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal
Singh, N., Yadav, S. S., Rao, A. S., Nandal, A., Kumar, S., Ganaie, S. A., & Narasihman, B. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113704 · Cited by 77
Structure–Activity Relationships for Withanolides as Inducers of the Cellular Heat-Shock Response
Wijeratne, E. M. K., Xu, Y.-M., Scherz‐Shouval, R., Marron, M. T., Rocha, D. D., Liu, M. X., Costa-Lotufo, L. V., Santagata, S., Lindquist, S. L., Whitesell, L. J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401279n · Cited by 75
Rhizospheric biological weapons for growth enhancement and Meloidogyne incognita management in Withania somnifera cv. Poshita
Saikia, S. K., Tiwari, S., & Pandey, R. (2013) · Biological Control · doi:10.1016/j.biocontrol.2013.01.014 · Cited by 74
Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models
Lee, W., Kim, T. H., Ku, S., Min, K., Lee, H., Kwon, T. K., & Bae, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.04.025 · Cited by 72
Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster
Manjunath, M. J., & Muralidhara (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-013-1219-0 · Cited by 69
Withania somnifera (Linn.) Dunal: a review of chemical and pharmacological diversity
Kalra, R., & Kaushik, N. (2017) · Phytochemistry Reviews · doi:10.1007/s11101-017-9504-6 · Cited by 69
Withanone, an Active Constituent from Withania somnifera, Affords Protection Against NMDA-Induced Excitotoxicity in Neuron-Like Cells
Dar, N. J., Bhat, J. A., Satti, N. K., Sharma, P. R., Hamid, A., & Ahmad, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0044-7 · Cited by 69
Self-citation
Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)
Modi, S. J., Tiwari, A., Ghule, C., Pawar, S., Saste, G., Jagtap, S., Singh, R., Deshmukh, A., Girme, A., & Hingorani, L. (2022) · Molecules · doi:10.3390/molecules27051476 · Cited by 68
Role of mitogen‐activated protein kinases and Mcl‐1 in apoptosis induction by withaferin A in human breast cancer cells
Hahm, E., Lee, J., & Singh, S. V. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22050 · Cited by 68
Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells
Lee, J., Sehrawat, A., & Singh, S. V. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2239-6 · Cited by 68
Inhibitors of Intracellular Signaling Pathways that Lead to Stimulated Epidermal Pigmentation: Perspective of Anti-Pigmenting Agents
Imokawa, G., & Ishida, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058293 · Cited by 68
The Integration of Metabolomics and Next-Generation Sequencing Data to Elucidate the Pathways of Natural Product Metabolism in Medicinal Plants
Scossa, F., Benina, M., Alseekh, S., Zhang, Y., & Fernie, A. R. (2018) · Planta Medica · doi:10.1055/a-0630-1899 · Cited by 69
Rational use of Ashwagandha in Ayurveda (Traditional Indian Medicine) for health and healing
Joshi, V. K., & Joshi, A. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114101 · Cited by 65
A Standardized Withania Somnifera Extract Significantly Reduces Stress-Related Parameters in Chronically Stressed Humans: A Double-Blind, Randomized, Placebo-Controlled Study
Auddy, B., Hazra, J., Mitra, A., Abedon, B., Ghosal, S., & Nagar, B. (2008) · Cited by 65
Withania somnifera (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review
Lerose, V., Ponticelli, M., Benedetto, N., Carlucci, V., Lela, L., Tzvetkov, N. T., & Milella, L. (2024) · Plants · doi:10.3390/plants13060771 · Cited by 66
An Aqueous Extract of Withania somnifera Root Inhibits Amyloid β Fibril Formation In Vitro
Kumar, S., Harris, R. J., Seal, C. J., & Okello, E. J. (2012) · Phytotherapy Research · doi:10.1002/ptr.3512 · Cited by 62
Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component
Dar, P. A., Singh, L. R., Kamal, M. A., & Dar, T. A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151125001751 · Cited by 61
Computational Evidence to Inhibition of Human Acetyl Cholinesterase by Withanolide A for Alzheimer Treatment
Grover, A., Shandilya, A., Agrawal, V., Bisaria, V. S., & Sundar, D. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.10507408 · Cited by 60
Multifunctional role of natural products for the treatment of Parkinson’s disease: At a glance
Rahman, M. M., Wang, X., Islam, M. R., Akash, S., Supti, F. A., Mitu, M. I., Harun-Or-Rashid, M., Aktar, M. N., Kali, M. S. K., Jahan, F. I., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.976385 · Cited by 60
Production of reactive oxygen species by withaferin A causes loss of type collagen expression and COX-2 expression through the PI3K/Akt, p38, and JNK pathways in rabbit articular chondrocytes
Yu, S., & Kim, S. J. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.08.026 · Cited by 59
Attenuation of Glutamate-Induced Excitotoxicity by Withanolide-A in Neuron-Like Cells: Role for PI3K/Akt/MAPK Signaling Pathway
Dar, N. J., Satti, N. K., Dutt, P., Hamid, A., & Ahmad, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0515-5 · Cited by 57
Self-citation
Neuroprotective effects of Withania somnifera in the SH-SY5Y Parkinson cell model
Wongtrakul, J., Thongtan, T., Kumrapich, B., Saisawang, C., & Ketterman, A. J. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08172 · Cited by 52
Antiparkinsonian Effects of Aqueous Methanolic Extract of Hyoscyamus niger Seeds Result From its Monoamine Oxidase Inhibitory and Hydroxyl Radical Scavenging Potency
Sengupta, T. K., Vinayagam, J., Nagashayana, N., Gowda, B., Jaisankar, P., & Mohanakumar, K. P. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0289-x · Cited by 51
Withania somnifera (L.) Dunal (Ashwagandha); current understanding and future prospect as a potential drug candidate
Bhat, J. A., Akther, T., Najar, R. A., Rasool, F., & Hamid, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1029123 · Cited by 51
The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice
Chonpathompikunlert, P., Boonruamkaew, P., Sukketsiri, W., Hutamekalin, P., & Sroyraya, M. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2166-0 · Cited by 49
Withania somnifera Improves Ischemic Stroke Outcomes by Attenuating PARP1-AIF-Mediated Caspase-Independent Apoptosis
Raghavan, A., & Shah, Z. A. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8907-2 · Cited by 47
Role of ashwagandha methanolic extract in the regulation of thyroid profile in hypothyroidism modeled rats
Abdel-Wahhab, K. G., Mourad, H. H., Mannaa, F. A. E., Morsy, F. A., Hassan, L. K., & Taher, R. F. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04721-x · Cited by 47
Nephroprotective Effect ofWithania somnifera:A Dose-Dependent Study
Jeyanthi, T., & Subramanian, P. (2009) · Renal Failure · doi:10.3109/08860220903150320 · Cited by 47
Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells
Halder, B., Singh, S., & Thakur, S. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137498 · Cited by 46
Effect of Withania somnifera Supplementation on Rotenone-Induced Oxidative Damage in Cerebellum and Striatum of the Male Mice Brain
Manjunath, M. J., & ., M. (2013) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524911313010007 · Cited by 45
Withania somnifera Prevents Morphine Withdrawal-Induced Decrease in Spine Density in Nucleus Accumbens Shell of Rats: A Confocal Laser Scanning Microscopy Study
Kasture, S. B., Vinci, S., Ibba, F., Puddu, A., Marongiu, M., Balasubramanian, M., Pisanu, A., Lecca, D., Zernig, G., & Acquas, E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9069-2 · Cited by 44
Withaferin A Analogs That Target the AAA+ Chaperone p97
Tao, S., Tillotson, J., Wijeratne, E. M. K., Xu, Y.-M., Kang, M., Wu, T., Lau, E. C., Mesa, C., Mason, D. J., Brown, R. V., et al. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00367 · Cited by 44
Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis
Vaidya, V. G., Naik, N., Ganu, G. P., Parmar, V., Jagtap, S., Saste, G., Bhatt, A., Mulay, V. P., Girme, A., Modi, S. J., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117603 · Cited by 43
Nootropic potential of Ashwagandha leaves: Beyond traditional root extracts
Wadhwa, R., Konar, A., & Kaul, S. C. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.09.001 · Cited by 43
Phytomedicine
Srivastava, A., Srivastava, P., Pandey, A., Khanna, V., & Pant, A. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814619-4.00025-2 · Cited by 49
Protection against cerebral infarction by Withaferin A involves inhibition of neuronal apoptosis, activation of PI3K/Akt signaling pathway, and reduced intimal hyperplasia via inhibition of VSMC migration and matrix metalloproteinases
Zhang, Q., GUO, Y.-D., Li, H.-M., Wang, R.-Z., Guo, S., & Du, Y. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.09.003 · Cited by 42
Efficacy of Natural Compounds in Neurodegenerative Disorders
Srivastava, P., & Yadav, R. S. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_7 · Cited by 43
Clinical safety and tolerability evaluation of Withania somnifera (L.) Dunal (Ashwagandha) root extract in healthy human volunteers
Vaidya, V. G., Gothwad, A., Ganu, G. P., Girme, A., Modi, S. J., & Hingorani, L. (2023) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2023.100859 · Cited by 40
Plant-Derived Natural Products for Parkinson’s Disease Therapy
Sengupta, T. K., Vinayagam, J., Singh, R. P., Jaisankar, P., & Mohanakumar, K. P. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_23 · Cited by 39
Potential clinical applications of Ashwagandha (Withania somnifera) in medicine and neuropsychiatry
D’Cruz, M., & Andrade, C. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2121699 · Cited by 40
Aqueous Leaf Extract of Withania somnifera as a Potential Neuroprotective Agent in Sleep-deprived Rats: a Mechanistic Study
Manchanda, S., Mishra, R., Singh, R., Kaur, T., & Kaur, G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9883-5 · Cited by 38
A Review on Pharmacological Profile of Withania somnifera (Ashwagandha).
Kaur, N., Niazi, J., & Raman, B. (2013) · HAL · Cited by 38
Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairment
Ahmed, M. E., Javed, H., Khan, M. M., Vaibhav, K., Ahmad, A., Khan, A., Tabassum, R., Islam, F., Safhi, M. M., & Islam, F. (2013) · PROTOPLASMA · doi:10.1007/s00709-013-0482-2 · Cited by 37
Self-citation
Withania somnifera - a magic plant targeting multiple pathways in cancer related inflammation
Kumar, P., Sharma, R., & Garg, N. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154137 · Cited by 37
Mucuna pruriens seeds in treatment of Parkinson’s disease: pharmacological review
Kasture, S. B., Mohan, M., & Kasture, V. S. (2013) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-013-0126-2 · Cited by 36
Alcoholic Extract of Bacopa monniera Linn. Protects Against 6-Hydroxydopamine-Induced Changes in Behavioral and Biochemical Aspects: A Pilot Study
Shobana, C., Kumar, R. R., & Sumathi, T. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9833-3 · Cited by 37
Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson′s disease model
Chandrashekhar, V. M., Shalavadi, M. H., Avinash, S., Sowmya, C. S., & Ramkishan, A. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.103275 · Cited by 34
Evaluation of toxicological and antioxidant potential of Nardostachys jatamansi in reversing haloperidol-induced catalepsy in rats
Ibrahim, M. O. (2010) · International Journal of General Medicine · doi:10.2147/ijgm.s9156 · Cited by 33
Complete Comparison Display (CCD) evaluation of ethanol extracts of Centella asiatica and Withania somnifera shows that they can non-synergistically ameliorate biochemical and behavioural damages in MPTP induced Parkinson's model of mice
Bhatnagar, M., Goel, I., Roy, T., Shukla, S. D., & Khurana, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177254 · Cited by 32
Functional and Morphological Correlates in the Drosophila LRRK2 loss-of-function Model of Parkinson’s Disease: Drug Effects of Withania somnifera (Dunal) Administration
Rose, F. D., Marotta, R., Poddighe, S., Talani, G., Catelani, T., Setzu, M. D., Solla, P., Marrosu, F., Sanna, E., Kasture, S. B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146140 · Cited by 31
An Extract of Withania somnifera Attenuates Endothelin‐1‐stimulated Pigmentation in Human Epidermal Equivalents through the Interruption of PKC Activity Within Melanocytes
Nakajima, H., Wakabayashi, Y., Wakamatsu, K., & Imokawa, G. (2011) · Phytotherapy Research · doi:10.1002/ptr.3552 · Cited by 30
Effect and Mechanism of Chinese Herbal Medicine on Parkinson's Disease
Zeng, B. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.02.004 · Cited by 29
Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents
Yenisetti, S. C., Manjunath, M. J., & ., M. (2016) · Recent Patents on CNS Drug Discovery · doi:10.2174/1574889810666160615014106 · Cited by 29
Withanolides against TLR4‐Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study
Purushotham, P. M., Kim, J., Jo, E., & Senthil, K. (2016) · Phytotherapy Research · doi:10.1002/ptr.5746 · Cited by 29
Piriformospora indica elicitation of withaferin A biosynthesis and biomass accumulation in cell suspension cultures of Withania somnifera
Ahlawat, S., Saxena, P., Ali, A., & Abdin, M. Z. (2015) · Symbiosis · doi:10.1007/s13199-015-0364-9 · Cited by 28
Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease
Ahmad, M., Yousuf, S., Khan, M. B., Ahmad, A. S., Saleem, S., Hoda, M. N., & Islam, F. (2006) · Human & Experimental Toxicology · doi:10.1191/0960327106ht635oa · Cited by 28
Self-citation
Natural antioxidants in the management of Parkinson’s disease: Review of evidence from cell line and animal models
Abdul-Latif, R., Stupans, I., Allahham, A., Adhikari, B., & Thrimawithana, T. R. (2021) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2021.03.007 · Cited by 30
Organic Farming Practice for Quality Improvement of Tea and Its Anti Parkinsonism Effect on Health Defense
Bagchi, A. (2015) · Journal of Physical Chemistry & Biophysics · doi:10.4172/2161-0398.1000178 · Cited by 27

Authors: Ahmad, M., Saleem, S., Ahmad, A. S., Ansari, M. A., Yousuf, S., Hoda, M. N., & Islam, F.
Affiliations: Jamia Hamdard (IN)
Corresponding author: Islam, Fakhrul
ORCID: Ahmad, Muzamil
Ahmad, Abdullah Shafique
Ansari, Mubeen Ahmad
Yousuf, Seema
Islam, Fakhrul
Venue: Human & Experimental Toxicology
Publisher: SAGE Publications
Published: 2005-03
Volume: 24
Issue: 3
Pages: 137-147
ISSN: 0960-3271 (ISSN-L)
1477-0903
DOI: 10.1191/0960327105ht509oa
OpenAlex: W1977817564
Cited by: 227
References: 51
Citations by year: 2026: 5 · 2025: 14 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 11 · 2020: 12 · 2019: 5 · 2018: 9 · 2017: 16 · 2016: 17 · 2015: 14 · 2014: 14 · 2013: 17 · 2012: 13
FWCI: 12.05
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Human & Experimental Toxicology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Keywords: Withania somnifera, ashwagandha extract, Parkinson's disease, 6-hydroxydopamine, neuroprotection, oxidative stress, striatum, antioxidant enzymes, lipid peroxidation, dopaminergic neurons, tyrosine hydroxylase, D2 receptor binding, catecholamines
MeSH terms: Animals, Behavior, Animal, Brain, Disease Models, Animal, Male, Plant Extracts, Oxidopamine, Rats, Wistar, Neuroprotective Agents, Parkinsonian Disorders, Withania, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks